AVTX
Avalo Therapeutics Inc.
$12.90
+$0.16(+1.26%)
42
Overall
60
Value
40
Tech
28
Quality
Market Cap
$281.44M
Volume
1.30M
52W Range
$4.20 - $24.27
Target Price
$46.18
Company Overview
| Mkt Cap | $281.44M | Price | $12.90 |
| Volume | 1.30M | Change | +1.26% |
| P/E Ratio | -3.6 | Open | $12.93 |
| Revenue | $59.0K | Prev Close | $12.74 |
| Net Income | $-78.3M | 52W Range | $4.20 - $24.27 |
| Div Yield | N/A | Target | $46.18 |
| Overall | 42 | Value | 60 |
| Quality | 28 | Technical | 40 |
No chart data available
Latest News
Avalo Therapeutics Shareholders Back Directors and Governance Changes
TipRanks Auto-Generated Newsdesk•a day ago
Analysts Offer Insights on Healthcare Companies: Avalo Therapeutics (AVTX) and Immunic (IMUX)
Brian Anderson•23 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVTX | $12.90 | +1.3% | 1.30M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |